Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
Mandro M, Siewe Fodjo JN, Mukendi D, Dusabimana A, Menon S, Haesendonckx S, Lokonda R, Nakato S, Nyisi F, Abhafule G, Wonya'Rossi D, Jakwong JM, Suykerbuyk P, Meganck J, Hotterbeekx A, Colebunders R.
Mandro M, et al. Among authors: meganck j.
PLoS Negl Trop Dis. 2020 Jan 10;14(1):e0007966. doi: 10.1371/journal.pntd.0007966. eCollection 2020 Jan.
PLoS Negl Trop Dis. 2020.
PMID: 31923177
Free PMC article.
Clinical Trial.